Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.73 | N/A |
| PEG Ratio (TTM) | 3.49 | N/A |
| P/S Ratio (TTM) | 17.10 | N/A |
| P/B Ratio (TTM) | 0.58 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 9.75 | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.13% | N/A |
| ROE (TTM) | 10.72% | N/A |
| Net Profit Margin (TTM) | 298.26% | N/A |
| ROIC 5YR AVG | 3.83% | N/A |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 41.78% | 32.58% | 28.97% |
| Revenue | 29.63% | 50.38% | 13.91% |
| Net Income | 42.03% | 32.04% | 28.20% |
| Cash Flow | N/A | N/A | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 21.91 | N/A |
| Quick Ratio (TTM) | 21.91 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | -0.27% | N/A |